Biodesix (BDSX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Biodesix (BDSX) is Neutral.

The composite score behind that read is +0.06, weighing +0.28 of bullish evidence against -0.34 bearish.

Biodesix last closed at $26.02, +1.52% on the session.

Against the IVW growth benchmark the position is +0.72% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

15 graded predictions for BDSX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Biodesix in the 1st percentile on return on equity, where 100 is best.

Biodesix is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $270.42M.

StockMap tracks Biodesix as the 69th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Biodesix ranks 18th of 85 in the group, against a group median of +0.00.